ACS: 180 AND ADVIA CENTAUR ANTI-THYROGLOBULIN IMMUNOASSAYS— 510(k) K012777

Substantially Equivalent

Bayer Corp.

FDA 510(k) clearance K012777 for ACS: 180 AND ADVIA CENTAUR ANTI-THYROGLOBULIN IMMUNOASSAYS, Substantially Equivalent on 2001-10-22. Applicant: Bayer Corp.. Device class: 2.

Clearance details

Applicant
Bayer Corp.
Product code
Code JZO
Device class
Class 2
Regulation
21 CFR 866.5870
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Tarrytown, NY, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code JZO

view all

More clearances from Bayer Corp.

view all

Recalls naming K012777

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K012777.

Data sourced from openFDA. This site is unofficial and independent of the FDA.